Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway.
Saved in:
| Title: | Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway. |
|---|---|
| Authors: | Mehta R; Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Panjab University, Chandigarh, 160 014, India., Bhandari R; Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Panjab University, Chandigarh, 160 014, India. akb10in@yahoo.co.uk., Kuhad A; Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Panjab University, Chandigarh, 160 014, India. anurag_pu@yahoo.com. |
| Source: | Metabolic brain disease [Metab Brain Dis] 2021 Oct; Vol. 36 (7), pp. 1833-1857. Date of Electronic Publication: 2021 Aug 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8610370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7365 (Electronic) Linking ISSN: 08857490 NLM ISO Abbreviation: Metab Brain Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1573-7365 |
|---|---|
| DOI: | 10.1007/s11011-021-00811-7 |
